Welcome to licensed pharmacies in Poland:

Non-prescription medicines delivery across Europe.

Frequently ordered: potency boosters (sildenafil OTC), quit smoking aids.

AS24 (Anonymous, 5.173.210.) Warszawa 17 months ago

Does Duodart increase the risk of developing prostate cancer?

I przeisany duodart on prostate psa-7 write that after taking the drug may increase the risk of prostate cancer please reply thank you very much

1 answer, 1 subscriber

* required field

You can drag the photo file here.

* required field

Notify of a new answer.
Other messages will not be sent.

Ewa Pilch Pharmacist, Editor

17 months ago

According to the package leaflet of Duodart, clinical studies have shown that patients at increased risk of developing severe prostate cancer are at increased risk of developing severe prostate cancer when using Duodart. However, the mechanism of effect of the drug on the development of severe prostate cancer has not been established. Due to the increased risk of developing cancer, it is recommended to regularly perform PSA determinations and consult a doctor. I enclose a link where you can check the availability of the drug and make a reservation at the pharmacy of your choice: https://www.gdziepolek.pl/produkty/25573/duodart-kapsulki/apteki The use of Duodart may affect the results obtained PSA tests. If you get increased results, I encourage you to consult a doctor. You can also use the teleadvice offered, m.in. by the Gdziepolek.pl portal: https://www.gdziepolek.pl/telekonsultacja The decision to use or stop using the medicine should be made after consultation with your doctor, who will assess whether the benefits of using the medicine outweigh the possible risks in your case.

Appreciate the answerer and highlight the question on the home page
User questions and answers that provide feedback about products are not verified for the purchase or use of the product. Companies often order anonymous comments to form positive opinions about their products, or negative ones about competitors. Therefore, be guided by the information in the pharmacists' responses in the first place.

Specialists